0IL8.LKyntra Bio, Inc.

À propos

Kyntra Bio, Inc. is a biopharmaceutical enterprise focused on the entire spectrum of therapeutic innovation, from discovering new compounds to developing and commercializing them. Leveraging profound insights into hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology, the company strives to engineer effective medicinal solutions for anemia, fibrotic conditions, and various forms of cancer. Founded by Thomas B. Neff on September 29, 1993, Kyntra Bio, Inc. maintains its corporate headquarters in San Francisco, California.

www.kyntrabio.com

Statistiques clés

Capitalisation

30.30M

BPA

45.36

Rendement dividende

0.00%

Bêta

0.99

P/B

-1.17

ROE

-435.8%

Secteur

Healthcare

Industrie

Medical - Pharmaceuticals

PDG

Thane Wettig

Employés

225

Date IPO

2018-01-29

Pays

US